Imaging Biomarker for Addiction Treatment Outcome


*fMRI image courtesy of Courtesy Steve Smith, FMRIB
*MRS image courtesy of Allen D. Elster, MRIquestions.com

For: Physician Health Programs (PHPs), PHP Participants, and Treatment Centers who treat healthcare professionals.

What: Learn how you can help contribute to the Federation of State Physician Health Programs (FSPHP)-National Institute on Drug Abuse (NIDA) Imaging Biomarker Study.

Why: Physicians (and other health care workers) have a long and storied history of studying themselves for the good of humankind.

The FSPHP and NIDA are supporting important work to understand how neural circuitry and human physiology are changed by addiction and repaired by recovery.

This NIH IRB-approved study, which is being conducted by the Neuroimaging Research Branch (NRB) at NIDA in collaboration with the FSPHP, is recruiting 500 PHP (or PHP equivalent) participants.  The goal of the research is to optimize the efficacy of currently available therapeutics by identifying brain biomarkers that can help assess the current severity of an individual’s substance use disorder (SUD), follow treatment progress and predict treatment outcome. 

Those who may be eligible for the study are: 

  • healthcare professionals enrolled in a PHP (or equivalent program)
  • diagnosed with a severe substance use disorder
  • 21 years or older


Collaboration between NIDA and FSPHP

The collaboration between NIDA and FSPHP helps ensure that this valuable research project can be completed with consideration for both research and quality clinical care. Together, we have established guidelines to assist PHP and Treatment Center staff with determining the appropriate methods for advertising the study. This study is approved by both the NIH IRB and the FSPHP research committee.

Study Investigators, Coordinators, and Collaborators

How PHP Participants Can Get Involved

How Physician Health Programs Can Get Involved

How Treatment Centers Working with PHP Participants Can Get Involved

More Information about the Study

Contact Betty Jo Salmeron, M.D. directly at 443-740-2651 or [email protected] to learn more about this unique, exciting, and vitally-important research study!